Haldex annual statement 2014 A year with solid growth and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Haldex annual statement 2014

A year with solid growth and improved profitability Net sales for 2014 totaled SEK 4,380 (3,920) m, equivalent to growth of 12% compared with the same period of the previous year. After currency adjustments, net sales increased by 8%. Net sales for Q4 amounted to SEK 1,092 (908) m, equivalent to growth of 10% after currency adjustments. Operating income for 2014 excluding one-off items amounted to SEK 408 (281) m, which is equivalent to an operating margin of 9.3 (7.2)%. Including one-off items, operating income was SEK 233 (153) m and the operating margin was 5.3 (3.9)%. Operating income for Q4 excluding one-off items amounted to SEK 101 (66) m, corresponding to an operating margin of 9.3 (7.3)%. Net income was impacted by one-off items in the amount of SEK 175 (128) m for the full year, and in the amount of SEK 69 (13) m for Q4. SEK 112 (128) m of the total amount of one-off items are attributable to the restructuring program. In November, Haldex launched a field inspection campaign of one of its actuator models in the North American market. Based on a thorough analysis of the field inspection results, an additional root cause, that can occur during special conditions, has been identified. Haldex has therefore decided to extend the campaign to include product replacements. The cost is estimated at SEK 65 m. This amount replaces the previous estimate of SEK 35 m, which was announced in the Q3 interim report. The entire amount had a negative impact on earnings in Q4 as a one-off item. Net income after tax for 2014 totaled SEK 107 (38) m and the earnings per share for 2014 totaled SEK 2.32 (0.80). The corresponding figures for Q4 are SEK 17 (12) m for net income after tax and SEK 0.38 (0.26) for earnings per share. Cash flow from operating activities amounted to SEK 435 (282) m for the full year and SEK 204 (76) m for Q4. The Board of Directors of Haldex proposes to the Annual General Meeting that a dividend of SEK 3.00 (2.00) per share shall be distributed. Key figures for October – December 2014 (same period previous year in brackets) · Net sales, SEK m   1,092 (908) · Operating income, excl. one-off items, SEK m   101 (66) · Operating income, SEK m   32 (53) · Operating margin, excl. one-off items, %   9.3 (7.3) · Operating margin, %   3.0 (5.9) · Return on capital employed, excl. one-off items,%1    21.4 (14.6) · Return on capital employed,%1   12.2 (7.8) · Net income, SEK m   17 (12) · Earnings per share, SEK   0.38 (0.26) · Cash flow, operating activities, SEK m   204 (76) Key figures for full year 2014 (same period previous year in brackets) · Net sales, SEK m   4,380 (3,920) · Operating income, excl. one-off items, SEK m   408 (281) · Operating income, SEK m   233 (153) · Operating margin, excl. one-off items, %   9.3 (7.2) · Operating margin, %   5.3 (3.9) · Return on capital employed, excl. one-off items,%1    21.4 (14.6) · Return on capital employed,%1   12.2 (7.8) · Net income, SEK m   107 (38) · Earnings per share, SEK   2.32 (0.80) · Cash flow, operating activities, SEK m   435 (282) 1) Rolling twelve months Comment from Bo Annvik, President and CEO: “It is not without a certain sense of pride that I look back on the past year. We grew faster than the market in 2014 and also improved our profitability to a level Haldex has not seen in many years. We have worked on streamlining and concentrating our business over the past two years and we are now seeing the results of these efforts. The extensive customer agreements involving disc brakes we signed with customers such as Daimler serve as a foundation for us to continue to expand in this important product group. We have taken market shares in Europe and are well equipped when disc brake sales take off. Now that the German union negotiations are complete, we are seeing the end of the restructuring program that had been in progress since 2013. We can then focus more on investment projects instead of restructuring projects. The new R&D center in Pune, India has been established at the right time on a market that has begun to recover after several poor years. Our development engineers in the UK have just moved into the new R&D and testing center, which is part of the MIRA test track. With the new building in place, engineering and testing will be co-located, leading to shorter development cycles and greater customer orientation. Our long-term vision is for Haldex products to have zero errors. We are working very hard to constantly improve our operations and are already operating at a high level. In spite of this, we have a warranty case in North America requiring much attention in the form of a field inspection and product replacements. The failure rate is extremely low, 0.03%, but we of course take responsibility for our products and we want to be a good long-term partner to our customers. We are looking to consistently achieve a 10% operating margin, and this requires that our business be firing on all cylinders. In the latter half of 2014, we were able to put in place the last part of our strategy and we presented updated long-term financial targets. 2014 was a testament to our ability to profitably grow faster than the market and we will tirelessly continue onward in this direction in 2015. in addition to organic growth, we are also interested in complementary acquisitions. The future market situation does not look as positive as in 2014. We estimate an increase of produced trucks and trailers, but since they have already reached a high level, the relative growth rates on the market are expected to be lower than in 2014. However, it is still a positive market to operate on, which gives us good prospects for a solid year in 2015.” Full interim report The full interim report is available at http://www.haldex.com/financialreports or at http://news.cision.com/haldex Press and analyst meeting Media and analysts are invited to a telephone conference at which the report will be presented with comments by Bo Annvik, President and CEO, and Andreas Ekberg, CFO. The presentation will also be webcasted live and you can participate with questions by telephone. Date & Time: Thursday February 12 at 10.00 CET The press conference is broadcasted at: http://edge.media -server.com/m/p/eergta9r To join the telephone conference: Sweden: +46 8 505 564 74 UK: +44 203 364 5374 Denmark: +45 354 455 79 USA: +1 855 753 2230 The webcast will also be available afterwards and you can download the Interim report and the presentation from Haldex website: http://www.haldex.com/financialreports For further information, please contact: Bo Annvik, President & CEO, +46 418 476000 Catharina Paulcén, SVP Corporate Communications, catharina.paulcen@haldex.com or +46 418-476157 Haldex AB (publ) is required to publish the above information under the Swedish Financial Instruments Trading Act. The information was submitted for publication on February 12, 2015 at 7.20 am CET. About Haldex With more than 100 years of intensely focused innovation, Haldex holds unrivaled expertise in brake systems and air suspension systems for heavy trucks, trailers and buses. We live and breathe our business delivering robust, technically superior solutions born from deep insight into our customers’ reality. By concentrating on our core competencies and following our strengths and passions, we combine both the operating speed and flexibility required by the market. Collaborative innovation is not only the essence of our products – it is also our philosophy. Our 2,235 employees, spread on four continents, are constantly challenging the conventional and strive to ensure that the products we deliver create unique value for our customers and all end-users. We are listed on the Nasdaq Stockholm Stock Exchange and have net sales of approximately 4 billion SEK.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 14

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 19

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 18

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 17

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 15

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 10

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 18

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Flying Bikes Market Expansion: A Journey to New Heights

Updated Category News Views 155

Flying Bikes Market Growth Projections The global flying bikes market is currently on an impressive trajectory. Originally valued at US$ 80.6 billion, it is anticipated to reach an astounding US$ 377.5 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 18.7% during this period. Innovative Performance Metrics Driving Demand Performance metrics for...

Continue Reading
Diversified Energy Enhances Portfolio with New Acquisition Deal

Updated Category News Views 205

Acquisition of Natural Gas Properties by Diversified Energy Bolt-on Acquisition Increases Coal Mine Methane Environmental Credit Cash Flow, Expands Midstream Infrastructure, and Enhances Southern Appalachia Prices Strategic Refinance Incorporates 40% Improvement in Cash Flow from New Hedges and an Innovative Master Trust Structure Solidifies Diversified as the Leading...

Continue Reading
MetroCity Bankshares and First IC Corporation Merge for Growth

Updated Category News Views 129

Strategic Merger of MetroCity Bankshares and First IC Corporation MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced an exciting development as it has secured all necessary regulatory approvals for its merger with First IC Corporation (OTCEM: FIEB). This strategic combination aims to enhance their banking services and expand their operational footprint across several...

Continue Reading
Crown's Revenue Surges in First Quarter Financial Update

Updated Category News Views 178

Crown Electrokinetics Corp. Financial Performance Update Crown Electrokinetics Corp. (NASDAQ: CRKN) has recently released its financial results, marking significant developments for the first quarter of 2025. This summary includes insights into revenue growth, operational accomplishments, and strategic advancements that highlight the company’s evolving presence in the...

Continue Reading
Eileen Revamps Retail Dynamics with New Investment Boost

Updated Category News Views 6

Capital Surge Fuels Eileen's Ambitious Expansion Now, here's something that's bound to shake up the retail tech scene. Eileen Inc., a fresh face in retail technology, just grabbed a strategic investment from DisPact Ventures. This isn't just another drop in the bucket; it's throwing serious weight into their operations to gear up for a monstrous scale. The injection into...

Continue Reading